VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog
← Pulse/Companies/Compare
Assort Health
VS
Flare Therapeutics

Biotech comparison — funding, valuation, and investors, sourced from Value Add Pulse coverage.

AH
Assort Health

Assort Health builds AI voice agents that automate patient access workflows for healthcare organizations, including scheduling, intake, referrals, and insurance verification.

2 Pulse stories
FT
Flare Therapeutics

Flare Therapeutics is a clinical-stage biotech developing small-molecule drugs that target transcription factors, including a first-in-class ARON-targeting degrader for prostate cancer.

2 Pulse stories
Total Raised
$222M
$290M
Assort HealthFlare Therapeutics
Last Valuation
$1.2B
Assort HealthFlare Therapeutics
Biotech
Sector
Biotech
2023
Founded
2021
San Francisco, California
HQ
Cambridge, Massachusetts
Private
Status
Private
Assort Health investors
Menlo VenturesLightspeed Venture PartnersFelicisFirst Round CapitalChemistryLiquid 2 VenturesQuiet CapitalA* Capital
Flare Therapeutics investors
Third Rock VenturesNextech InvestPfizer VenturesBoxer CapitalGordonMD Global InvestmentsInvusCasdin CapitalEli Lilly and Company

Data from Value Add Pulse coverage and company research — see the full threads for Assort Health and Flare Therapeutics.

@Trace_Cohen·t@nyvp.com